UNSPSC 85445707: The diagnosis of antihyperlipidaemic and antiarteriosclerotic drugs

In this classification, this covers the group of activities that yields a diagnosis of antihyperlipidaemic and antiarteriosclerotic drugs. Antihyperlipidaemic and antiarteriosclerotic drugs is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y52.6.

UNSPSC 85445707 The diagnosis of antihyperlipidaemic and antiarteriosclerotic drugs is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The code's title describes pharmaceutical diagnostics, yet the three most recent opportunities tagged under it are unrelated: San Mateo Medical Center is procuring a diagnostic imaging Picture Archiving and Communication System (PACS), Birdville Independent School District is soliciting special education contracted services, and Santa Clara County Health System is recruiting temporary health professional staffing vendors across ancillary clinical categories. None of these solicitations involve antihyperlipidaemic, antiarteriosclerotic, or other lipid-managing diagnostic products or services. The code appears to see little or no relevant procurement activity in state and local contracting right now.

The geographic spread of the three posted opportunities spans California (San Mateo County and Santa Clara County) and Texas (Tarrant County), but these examples do not reflect procurement under the code's actual scope. San Mateo Medical Center's RFP for enterprise-grade PACS with EPIC integration closed October 21, 2026, Birdville Independent School District's RFQ for special education services closed October 21, 2026, and Santa Clara County Health System's non-exclusive, multiple-award qualification RFQ for temporary health professional staffing closed October 7, 2026. Without recent opportunities that align with the code's stated focus on antihyperlipidaemic and antiarteriosclerotic drug diagnostics, the code signals minimal current activity in its intended category among state and local buyers.